FrankTheTooth,,2019-05-30 10:10:00,6.745,Pfenex PFNX said Thursday the European Medicines Agency has accepted the Marketing Authorization Application MAA submitted by its partner Alvogen for PF708 which is being proposed as a therapeutic equivalent in the treatment of osteoporosis to Eli Lillys LLY Forteo
